Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Cash from Discontinued Operations: 2016-2018

Historic Cash from Discontinued Operations for Soleno Therapeutics (SLNO) over the last 3 years, with Dec 2018 value amounting to -$1.4 million.

  • Soleno Therapeutics' Cash from Discontinued Operations rose 66.61% to -$188,000 in Q4 2018 from the same period last year, while for Dec 2018 it was -$1.4 million, marking a year-over-year increase of 55.10%. This contributed to the annual value of -$1.4 million for FY2018, which is 55.10% up from last year.
  • Per Soleno Therapeutics' latest filing, its Cash from Discontinued Operations stood at -$1.4 million for FY2018, which was up 55.10% from -$3.0 million recorded in FY2017.
  • Soleno Therapeutics' 5-year Cash from Discontinued Operations high stood at -$1.4 million for FY2018, and its period low was -$6.2 million during FY2016.
  • Moreover, its 3-year median value for Cash from Discontinued Operations was -$3.0 million (2017), whereas its average is -$3.5 million.
  • Data for Soleno Therapeutics' Cash from Discontinued Operations shows a peak YoY skyrocketed of 55.10% (in 2018) over the last 5 years.
  • Soleno Therapeutics' Cash from Discontinued Operations (Yearly) stood at -$6.2 million in 2016, then surged by 51.41% to -$3.0 million in 2017, then surged by 55.10% to -$1.4 million in 2018.